MEI Pharma, Inc. (Nasdaq: MEIP) is a pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma’s portfolio of drug candidates includes clinical stage candidates with differentiated mechanisms of action intended to address unmet medical needs and deliver improved benefit to patients, either as standalone treatments or in combination with other therapeutic options. For more information, please visit www.meipharma.com. Follow us on Twitter @MEI_Pharma and on LinkedIn.

https://www.meipharma.com/

Biotechnology

Mei Pharma, Inc. announced it raised $75 Million in an initial filing from an offering of $75 Million

Company Information

Related People

Funding Insights

Mei Pharma, Inc. announced it raised $75 Million in an initial filing from an offering of $75 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information